2562
V. Gotor-Ferna´ndez et al. / Tetrahedron: Asymmetry 17 (2006) 2558–2564
3
130.7 (C5), 144.5 (C9), 153.5 (C8). MS (EI+, m/z): 164
2JHH = 10.6 Hz, JHH = 2.6 Hz, 1H, H14), 5.39 (dd,
[(M+H)+, 100%]. Anal. Calcd for C10H13NO: C, 73.59;
2JHH = 17.2 Hz, JHH = 1.5 Hz, 1H, H14), 6.05 (m, 1H,
3
3
H, 8.03; N, 8.58. Found: C, 73.6; H, 8.0; N, 8.6.
H13), 6.98 (t, JHH = 7.4 Hz, 1H, H6), 7.17 (d,
20
3
½aꢀD ¼ ꢁ14:2 (c 0.5, CHCl3) for 99% ee of the (S)-
3JHH = 6.6 Hz, 1H, H4), 7.21 (d, JHH = 7.7 Hz, 1H, H5),
enantiomer.
7.84 (br s, 1H, H7); 13C NMR (CDCl3, 75.5 MHz): d 21.3
(C10), 35.9 (C3), 55.4 (C2), 65.9 (C12), 115.5 (C7), 117.9
(C14), 122.8 (C6), 125.1 (C4), 127.5 (C5), 130.0 (C8), 132.7
(C13), 141.6 (C9), 152.8 (C11). MS (EI+, m/z): 218
[(M+H)+, 100%], 240 [(M+Na)+, 8%]. Anal. Calcd for
4.2.3. 5-Fluoro-2-methylindoline 5c. 79% Isolated yield. Rf
(20% EtOAc/hexane): 0.31; IR (NaCl): m 3375, 3038, 2964,
2927, 0360, 1609, 1487, 1446, 1379, 1235, 1215, 1125, 937,
C13H15NO2: C, 71.87; H, 6.96; N, 6.45. Found: C, 71.9;
1
860, 806 cmꢁ1; H NMR (CDCl3, 300.13 MHz): d 1.29 (d,
20
H, 6.9; N, 6.5. ½aꢀD ¼ ꢁ47:4 (c 0.5, CHCl3) for 97% ee of
2
3JHH = 6.3 Hz, 3H, H10), 2.63 (dd, JHH = 15.7 Hz,
the (R)-enantiomer.
2
3JHH = 8.0 Hz, 1H, H3), 3.12 (dd, JHH = 15.8 Hz,
3JHH = 8.6 Hz, 1H, H3), 3.43 (br s, 1H, NH), 4.00 (m,
1H, H2), 6.50 (dd, JHH = 8.4 Hz, 4.5 Hz, 1H, H4), 6.71
(m, 1H, H7), 6.82 (dd, JHH = 2.5 Hz, 1.2 Hz, 1H, H6);
13C NMR (CDCl3, 75.5 MHz): d 21.7 (C10), 37.6 (C3),
55.5 (C2), 109.0 (C4, JCF = 8.0 Hz), 111.6 (C6, JCF = 24
Hz), 112.7 (C7, JCF = 23 Hz), 130.3 (C9, JCF = 8.0 Hz),
146.4 (C8), 156.7 (C5, JCF = 233 Hz). MS (EI+, m/z): 230
[(2M)+, 100%], 152 [(M+H)+, 20%], 151 [(M)+, 12%].
4.3.2. 2-Phenylindoline allyl carbamate 6a. 97% Isolated
yield. Rf (5% EtOAc/hexane): 0.22; Mp = 68–69 ꢁC.
IR(KBr): m 2476, 3414, 3031, 2950, 2361, 1702, 1599,
1485, 1403, 1315, 1272, 1144, 1046, 997, 950, 846 cmꢁ1
;
1H NMR (CDCl3, 300.13 MHz):
d
3.04 (dd,
2JHH = 16.5 Hz, JHH = 3.0 Hz, 1H, H3), 3.76 (dd,
3
2JHH = 16.3 Hz, JHH =10.5 Hz 1H, H3), 4.65 (br s, 2H,
3
H15), 5.15 (br s, 2H, H17), 5.52 (dd, JHH = 10.2, 2.4 Hz,
1H, H2), 5.80 (br s, 1H, H16), 7.06 (t, JHH = 7.2 Hz, 1H,
H6), 7.25 (m, 7H, H4+H5+2H11+2H12+H13), 7.95 (br s,
1H, H7); 13C NMR (CDCl3, 75.5 MHz): d 37.9 (C3), 62.5
(C2), 66.0 (C15), 115.0 (C7), 117.5 (C17), 123.1 (C6), 124.9
(C4), 125.4 (2C11), 127.4, 127.8 (C5+C13), 128.7 (2C12),
129.5 (C10), 132.4 (C16), 142.7 (C8), 143.9 (C9), 153.0
(C14). MS (EI+, m/z): 302 [(M+Na)+, 100%], 280
[(M+H)+, 20%]. Anal. Calcd for C18H17NO2F: C, 77.40;
Anal. Calcd for C9H10NF: C, 71.50; H, 6.67; N, 9.26.
20
Found: C, 71.6; H, 6.7; N, 9.2. ½aꢀD ¼ ꢁ10:1 (c 0.5, CHCl3)
for 99% ee of the (S)-enantiomer.
4.2.4. 3-Methylindoline 5d. 73% Isolated yield. Rf (20%
EtOAc/hexane): 0.57; IR (NaCl): m 3379, 3050, 2960,
1
2924, 2869, 1609, 1487, 1464, 1240, 1109, 1016 cmꢁ1; H
3
NMR (CDCl3, 300.13 MHz): d 1.35 (d, JHH = 6.5 Hz,
3
H, 6.13; N, 5.01. Found: C, 77.5; H, 6.2; N, 5.0.
3H, H10), 3.13 (t, JHH = 8.7 Hz, 1H, H2), 3.39 (m, 1H,
20
3
3
½aꢀD ¼ ꢁ93:0 (c 0.5, CHCl3) for 99% ee of the (R)-
H3), 3.72 (t, JHH = 8.5 Hz, 1H, H2), 6.67 (d, JHH
=
enantiomer.
7.8 Hz, 1H, H4), 6.77 (dt, JHH = 8.4 Hz, 6.2 Hz, 1H, H5),
7.04 (dt, JHH = 8.4 Hz, 7.5 Hz, 1H, H6), 7.07 (d,
3JHH = 6.5 Hz, 1H, H7); 13C NMR (CDCl3, 75.5 MHz): d
18.5 (C10), 36.5 (C3), 55.3 (C2), 109.4 (C4), 118.6 (C5),
123.3 (C7), 127.2 (C6), 134.2 (C9), 151.1 (C8). MS
(EI+, m/z): 134 [(M+H)+, 100%]. Anal. Calcd for
4.3.3. 2-Methyl-5-methoxyindoline allyl carbamate 6b.
.98% Isolated yield. Rf (15% EtOAc/hexane): 0.31; IR
(NaCl): m 2952, 2834, 1703, 1599, 1492, 1456, 1401, 1324,
1
1275, 1207, 1134, 1051, 1033, 995, 918, 810, 760 cmꢁ1; H
3
C9H11N: C, 81.16; H, 8.32; N, 10.52. Found: C, 81.1; H,
NMR (CDCl3, 300.13 MHz): d 1.30 (d, JHH = 6.2 Hz,
20
2
3
8.2; N, 10.5. ½aꢀD ¼ ꢁ30:2 (c 0.25, CHCl3) for 99% ee of
3H, H10), 2.60 (dd, JHH = 16.2 Hz, JHH = 1.6 Hz, 1H,
2
3
the (R)-enantiomer.
H3), 3.35 (dd, JHH = 16.2 Hz, JHH = 9.7 Hz 1H, H3),
3.77 (s, 3H, H11), 4.58 (m, 1H, H2), 4.73 (d, 3JHH = 4.4 Hz,
2
3
2H, H13), 5.26 (dd, JHH = 10.6 Hz, JHH = 1.3 Hz, 1H,
4.3. Typical experimental procedure for the preparation of
racemic allyl carbamates 3 and 6a–d
2
3
H15), 5.37 (dd, JHH = 17.2 Hz, JHH = 1.6 Hz, 1H, H15),
6.01 (m, 1H, H14), 6.73 (m, 2H, H4+H6), 7.75 (br s, 1H,
H7); 13C NMR (CDCl3, 75.5 MHz): d 21.2 (C10), 36.1
(C3), 55.7 (C11+C2), 65.8 (C13), 111.4 (C4), 112.1 (C6),
115.9 (C7), 117.7 (C15), 131.4 (C5), 132.9 (C14), 135.0
(C9), 152.6 (C12), 155.9 (C8). MS (EI+, m/z): 270
[(M+Na)+, 100%], 248 [(M+H)+, 20%]. Anal. Calcd for
To a solution of the corresponding indoline (0.31 mmol) in
dry CH2Cl2 under nitrogen atmosphere and at 0 ꢁC were
added pyridine (28 lL, 0.34 mmol) and allyl chloroformate
(37 lL, 0.34 mmol). The reaction was stirred at room tem-
perature for 3 h until complete consumption of the starting
material, then the solvent was evaporated and the crude
purified by flash chromatography.
C14H17NO3: C, 68.00; H, 6.93; N, 5.66. Found: C, 68.1;
20
H, 6.8; N, 5.6. ½aꢀD ¼ ꢁ54:6 (c 0.5, CHCl3) for 95% ee of
the (R)-enantiomer.
4.3.1. 2-Methylindoline allyl carbamate 3. 98% Isolated
yield. Rf (5% EtOAc/hexane): 0.30; IR (NaCl): m 2974,
1705, 1603, 1486, 1463, 1400, 1322, 1282, 1226, 1173,
4.3.4. 5-Fluoro-2-methylindoline allyl carbamate 6c. 85%
Isolated yield. Rf (5% EtOAc/hexane): 0.29; Mp = 41–
42 ꢁC; IR: m 3557, 3415, 2968, 2933, 1701, 1612, 1488,
1140, 1104, 1048, 995, 935 cmꢁ1
;
1H NMR (CDCl3,
1398, 1297, 1275, 1127, 1050, 997, 934, 822 cmꢁ1
;
1H
3
3
300.13 MHz): d 1.30 (d, JHH = 6.5 Hz, 3H, H10), 2.65
NMR (CDCl3, 300.13 MHz): d 1.31 (d, JHH = 6.5 Hz,
2
3
2
3
(dd, JHH = 16.0 Hz, JHH = 2.2 Hz, 1H, H3), 3.38 (dd,
3H, H10), 2.62 (dd, JHH = 16.2 Hz, JHH = 1.6 Hz, 1H,
2JHH = 16.0 Hz, JHH = 9.6 Hz 1H, H3), 4.60 (m, 1H,
H2), 4.76 (d, JHH = 5.0 Hz, 2H, H12), 5.26 (dd,
H3), 3.36 (dd, JHH = 16.2 Hz, JHH = 9.4 Hz 1H, H3),
4.60 (m, 1H, H2), 4.74 (d, JHH = 5.0 Hz, 2H, H12), 5.27
3
2
3
3
3